News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
977 Results
Type
Article (60)
Press Release (917)
Section
Business (269)
Deals (81)
Drug Development (128)
FDA (35)
Job Trends (13)
News (505)
Policy (31)
Tag
Adcomms (1)
Alliances (50)
Approvals (33)
Artificial intelligence (1)
Bankruptcy (2)
Best Places to Work (11)
Bladder cancer (15)
Cancer (40)
Cardiovascular disease (1)
Clinical research (136)
Collaboration (3)
Compensation (4)
C-suite (1)
Data (20)
Diagnostics (6)
Earnings (133)
Events (179)
Executive appointments (1)
FDA (46)
Government (3)
Guidances (1)
Healthcare (16)
Immunology and inflammation (2)
Indications (2)
Infectious disease (6)
IPO (50)
Job creations (2)
Legal (1)
Lung cancer (1)
Lymphoma (1)
Medical device (8)
Medtech (8)
Mergers & acquisitions (31)
NextGen: Class of 2026 (7)
Non-profit (2)
Patents (1)
People (88)
Phase I (14)
Phase II (44)
Phase III (76)
Pipeline (6)
Policy (1)
Postmarket research (10)
Preclinical (6)
Prostate cancer (10)
Radiopharmaceuticals (1)
Rare diseases (1)
Regulatory (43)
RSV (2)
Startups (4)
Vaccines (2)
Date
Last 30 days (3)
Last 365 days (71)
2026 (3)
2025 (72)
2024 (70)
2023 (58)
2022 (69)
2021 (76)
2020 (110)
2019 (81)
2018 (54)
2017 (42)
2016 (26)
2015 (56)
2014 (54)
2013 (23)
2012 (34)
2011 (30)
2010 (44)
Location
Asia (51)
Australia (6)
California (6)
Europe (130)
Florida (3)
Japan (2)
Massachusetts (7)
New Jersey (62)
New York (4)
Northern California (4)
Ohio (4)
Pennsylvania (3)
Southern California (1)
United States (92)
Utah (3)
977 Results for "urogen".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Approvals
Moderna, Merck, UroGen, Score RSV and Cancer Nods in June
The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an approval in bladder cancer, and more key regulatory nods from the past month.
June 30, 2025
·
9 min read
·
Tristan Manalac
Press Releases
UroGen Pharma to Present at the Piper Sandler 37th Annual Healthcare Conference
November 26, 2025
·
1 min read
Press Releases
UroGen Pharma to Present at Guggenheim Securities Healthcare Innovation Conference
November 5, 2025
·
1 min read
Press Releases
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 5, 2025
December 5, 2025
·
2 min read
Press Releases
UroGen Reports Third Quarter 2025 Financial Results as ZUSDURI™ Launch Gains Momentum
November 7, 2025
·
22 min read
Press Releases
UroGen Pharma to Report Third Quarter 2025 Financial Results on Thursday, November 6th, 2025
October 31, 2025
·
1 min read
Press Releases
UroGen Pharma to Present at Upcoming September 2025 Investor Conferences
August 22, 2025
·
1 min read
Bladder cancer
UroGen’s Bladder Cancer Drug Wins FDA Approval Over Adcomm’s Objections
The FDA’s Oncologic Drugs Advisory Committee narrowly voted against the approval of Zusduri, citing the lack of a completely randomized study to back up the application.
June 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 8, 2025
September 9, 2025
·
2 min read
Press Releases
UroGen Reports 77.8% Three-Month Complete Response Rate from Phase 3 UTOPIA Trial of UGN-103 and Receives FDA Agreement on NDA Submission Strategy in Recurrent LG-IR-NMIBC Based on UTOPIA Trial
November 7, 2025
·
11 min read
1 of 98
Next
